KURAKura Oncology, Inc.

$792M

FY 2012 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$22,341

Operating Income

-$23,440

Net Income

-$27,040

EPS (Diluted)

$-0.01

Cash Flow

Operating Cash Flow

-$22,678

Free Cash Flow

-$22,678

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$8,302

Total Liabilities

$103,648

Stockholders' Equity

-$95,346

Cash & Equivalents

$4,802

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$22,341	-$23,440	+4.7%
Operating Income	-$23,440	-$20,509	-14.3%
Net Income	-$27,040	-$22,395	-20.7%

KURA FY 2012 Earnings — Kura Oncology, Inc. Revenue & Financial Results | Market Cap Arena